Low-dose suramin in autism spectrum disorder: a small, phase I/II, randomized clinical trial.
about
Suramin increases cartilage proteoglycan accumulation in vitro and protects against joint damage triggered by papain injection in mouse knees in vivo.Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases.Purinergic system in psychiatric diseases.GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.Microglia and Autism Spectrum Disorder: Overview of Current Evidence and Novel Immunomodulatory Treatment Options
P2860
Low-dose suramin in autism spectrum disorder: a small, phase I/II, randomized clinical trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Low-dose suramin in autism spe ...... II, randomized clinical trial.
@en
type
label
Low-dose suramin in autism spe ...... II, randomized clinical trial.
@en
prefLabel
Low-dose suramin in autism spe ...... II, randomized clinical trial.
@en
P2093
P2860
P921
P356
P1476
Low-dose suramin in autism spe ...... II, randomized clinical trial.
@en
P2093
A Taylor Bright
Alan Lincoln
Brooke Curtis
Cynthia Adams
Deyna A Arellano
Edmund V Capparelli
Gail E Reiner
Jane C Naviaux
Jeanne Townsend
P2860
P304
P356
10.1002/ACN3.424
P50
P577
2017-05-26T00:00:00Z